Creating nanogels to treat Alzheimer's disease
Official title: Development of Biotherapeutic Nanogels for Alzheimers Disease Treatment
Funded at Florida International University · NIH-10890398 · Data updated 2026-11-12
This study is testing new tiny gel-like treatments that could help people with Alzheimer's by targeting specific markers of the disease, with the hope of slowing down its progress.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Florida International University NIH-funded |
| Lab location | 1 site (Miami, United States) |
| Project start | September 15, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $147,500 |
| NIH project number | 1R03AG087475-01 |
| Project ID | NIH-10890398 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias.
✕Less likely to help
Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.
What this research studies
This research focuses on developing biotherapeutic nanogels aimed at treating Alzheimer's disease, a condition affecting millions worldwide. The approach involves using innovative nanogels that can target specific biomarkers associated with Alzheimer's, potentially halting or delaying disease progression. These nanogels are designed to be biocompatible and capable of crossing the blood-brain barrier, which is crucial for effective treatment. The study will explore how these nanogels interact with amyloid-beta proteins, which are linked to Alzheimer's pathology.
Why it matters
Potential benefit: If successful, this research could lead to a new treatment that significantly slows down the progression of Alzheimer's disease.
How similar studies have gone: While the use of nanogels in treating Alzheimer's is a novel approach, similar strategies targeting amyloid-beta have shown promise in preliminary studies.
Where this research is happening
-
Florida International University
Miami, United States Active
Researchers
- Principal investigator: Vashist, Arti — Florida International University
- Study coordinator: Vashist, Arti
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Cognitive SuperAging: Exploring why some octogenarians stay sharp in memory
This NIH grant studies why a small group of people aged 80+ keep memory skills as good as much younger people, hoping to understand how to protect memory as we age.
-
CLU's role in Alzheimer's disease pathogenesis
Researchers are studying how the CLU gene may drive brain changes in Alzheimer's disease and how targeting CLU could lead to safer treatments.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.